Cargando…

Icaritin Reduces Oral Squamous Cell Carcinoma Progression via the Inhibition of STAT3 Signaling

Icaritin, a traditional Chinese medicine, possesses antitumor activity. The current study aimed to investigate icaritin effect and potential mechanism on oral squamous cell carcinoma (OSCC) development. OSCC cells proliferation, apoptosis, and autophagy were analyzed after incubation with icaritin a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Jian-Guang, Lu, Rui, Ye, Xiao-Jing, Zhang, Jing, Tan, Ya-Qin, Zhou, Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297765/ https://www.ncbi.nlm.nih.gov/pubmed/28085115 http://dx.doi.org/10.3390/ijms18010132

Ejemplares similares

Icaritin Inhibits JAK/STAT3 Signaling and Growth of Renal Cell Carcinoma
por: Li, Shasha, et al.
Publicado: (2013)

Icaritin suppresses multiple myeloma, by inhibiting IL-6/JAK2/STAT3
por: Zhu, Shicong, et al.
Publicado: (2015)

Icaritin: A Novel Natural Candidate for Hematological Malignancies Therapy
por: Yang, Xiao-Jing, et al.
Publicado: (2019)

Icaritin inhibits CDK2 expression and activity to interfere with tumor progression
por: Zhang, Chao, et al.
Publicado: (2022)

Icaritin reduces prostate cancer progression via inhibiting high-fat diet-induced serum adipokine in TRAMP mice model
por: Wu, Xiaobo, et al.
Publicado: (2020)

Icaritin inhibits decidualization of endometrial stromal cells
por: Le, Aiwen, et al.
Publicado: (2017)

A comparative study on the in vitro and in vivo antitumor efficacy of icaritin and hydrous icaritin nanorods
por: Li, Haowen, et al.
Publicado: (2020)

Icaritin-Induced FAM99A Affects GLUT1-Mediated Glycolysis via Regulating the JAK2/STAT3 Pathway in Hepatocellular Carcinoma
por: Zheng, Xia, et al.
Publicado: (2021)

AMPK-autophagy inhibition sensitizes icaritin-induced anti-colorectal cancer cell activity
por: Zhou, Chunxian, et al.
Publicado: (2017)

Cytotoxic Effect of Icaritin and Its Mechanisms in Inducing Apoptosis in Human Burkitt Lymphoma Cell Line
por: Li, Zi-Jian, et al.
Publicado: (2014)

CADM1 inhibits squamous cell carcinoma progression by reducing STAT3 activity
por: Vallath, Sabari, et al.
Publicado: (2016)

A Novel Semisynthetic Molecule Icaritin Stimulates Osteogenic Differentiation and Inhibits Adipogenesis of Mesenchymal Stem Cells
por: Sheng, Hui, et al.
Publicado: (2013)

Icaritin, an Exogenous Phytomolecule, Enhances Osteogenesis but Not Angiogenesis—An In Vitro Efficacy Study
por: Yao, Dong, et al.
Publicado: (2012)

Icaritin Shows Potent Anti-Leukemia Activity on Chronic Myeloid Leukemia In Vitro and In Vivo by Regulating MAPK/ERK/JNK and JAK2/STAT3 /AKT Signalings
por: Zhu, Jian feng, et al.
Publicado: (2011)

Signal regulatory protein α associated with the progression of oral leukoplakia and oral squamous cell carcinoma regulates phenotype switch of macrophages
por: Ye, Xiaojing, et al.
Publicado: (2016)

Icaritin Inhibits Migration and Invasion of Human Ovarian Cancer Cells via the Akt/mTOR Signaling Pathway
por: Gao, Lvfen, et al.
Publicado: (2022)

Icaritin Derivative IC2 Induces Cytoprotective Autophagy of Breast Cancer Cells via SCD1 Inhibition
por: Wang, Yi-Xuan, et al.
Publicado: (2023)

Bioactive PLGA/tricalcium phosphate scaffolds incorporating phytomolecule icaritin developed for calvarial defect repair in rat model
por: Shi, Guang-Sen, et al.
Publicado: (2020)

Highly efficient bioconversion of icariin to icaritin by whole-cell catalysis
por: Lin, Yu, et al.
Publicado: (2023)

STAT3 Promotes Invasion and Aerobic Glycolysis of Human Oral Squamous Cell Carcinoma via Inhibiting FoxO1
por: Zheng, Min, et al.
Publicado: (2019)

Pharmacokinetics and metabolism of icaritin in rats by UPLC‐MS/MS
por: Huang, Zhen‐Wu, et al.
Publicado: (2019)

Icaritin, a novel FASN inhibitor, exerts anti-melanoma activities through IGF-1R/STAT3 signaling
por: Wu, Jinfeng, et al.
Publicado: (2016)

Icaritin inhibits PD‐L1 expression by Targeting Protein IκB Kinase α
por: Mo, Dongliang, et al.
Publicado: (2021)

Icaritin Causes Sustained ERK1/2 Activation and Induces Apoptosis in Human Endometrial Cancer Cells
por: Tong, Jing-Shan, et al.
Publicado: (2011)

Icaritin promotes apoptosis and inhibits proliferation by down-regulating AFP gene expression in hepatocellular carcinoma
por: Li, Hui, et al.
Publicado: (2021)

Nuciferine Inhibits Oral Squamous Cell Carcinoma Partially through Suppressing the STAT3 Signaling Pathway
por: Xie, Ji-Rong, et al.
Publicado: (2023)

Icaritin promotes the osteogenesis of bone marrow mesenchymal stem cells via the regulation of sclerostin expression
por: Wei, Qiushi, et al.
Publicado: (2020)

Exploring the pharmacological mechanisms of icaritin against nasopharyngeal carcinoma via network pharmacology and experimental validation
por: Liu, Minglu, et al.
Publicado: (2022)

Icaritin promotes the osteogenesis of bone marrow mesenchymal stem cells via the regulation of sclerostin expression
por: Wei, Qiushi, et al.
Publicado: (2023)

Icaritin inhibits the expression of alpha-fetoprotein in hepatitis B virus-infected hepatoma cell lines through post-transcriptional regulation
por: Zhang, Chao, et al.
Publicado: (2016)

Shp2 Inhibits Proliferation of Esophageal Squamous Cell Cancer via Dephosphorylation of Stat3
por: Qi, Chen, et al.
Publicado: (2017)

Icaritin induces lytic cytotoxicity in extranodal NK/T-cell lymphoma
por: Wu, Ting, et al.
Publicado: (2015)

Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma
por: Lu, Yi, et al.
Publicado: (2022)

Investigating the effect of Icaritin on hepatocellular carcinoma based on network pharmacology
por: Xue, Zhong, et al.
Publicado: (2023)

Icaritin ameliorates RANKL-mediated osteoclastogenesis and ovariectomy-induced osteoporosis
por: Huang, Jun-ming, et al.
Publicado: (2023)

Icaritin enhances the efficacy of cetuximab against triple-negative breast cancer cells
por: Yin, Li, et al.
Publicado: (2020)

Antitumor effect of toosendanin on oral squamous cell carcinoma via suppression of p-STAT3
por: Wu, Ye, et al.
Publicado: (2023)

Flavopereirine Suppresses the Progression of Human Oral Cancer by Inhibiting the JAK-STAT Signaling Pathway via Targeting LASP1
por: Xu, Junwu, et al.
Publicado: (2021)

Icaritin Induces Anti-tumor Immune Responses in Hepatocellular Carcinoma by Inhibiting Splenic Myeloid-Derived Suppressor Cell Generation
por: Tao, Huimin, et al.
Publicado: (2021)

A novel semisynthesized small molecule icaritin reduces incidence of steroid-associated osteonecrosis with inhibition of both thrombosis and lipid-deposition in a dose-dependent manner
por: Zhang, Ge, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_7huucsh0h4027l9s1kmd8b16ir